Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00ARS
|
|||
| Former ID |
DIB004431
|
|||
| Drug Name |
MER-3001
|
|||
| Synonyms |
Insulin B chain therapeutics (type 1 diabetes), Mercia Pharma/Joslin Diabetes Center
Click to Show/Hide
|
|||
| Indication | Type-1 diabetes [ICD-11: 5A10; ICD-9: 250] | Phase 2 | [1] | |
| Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 2 | [2] | ||
| Company |
Mercia Pharma Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of Mercia Pharma Inc. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.